MultiCare Offers New Five-Day Breast Cancer Treatment
December 15, 2008
TACOMA, Wash. - MultiCare Regional Cancer Center at Tacoma General Hospital is one of the first facilities in the Pacific Northwest to offer the SAVI® applicator.
full story [PDF - 23.5Kb]
Largest SAVI Study Calls Experience "Outstanding"
September 23, 2008
ALISO VIEJO, Calif. - Clinical experience with the SAVI® applicator has been outstanding, according to a poster presented at the 2008 Breast Cancer Symposium in September. The retrospective study evaluated the first 102 SAVI patients, making it the largest clinical evaluation of the device to date.
full story
Study Shows Radiation Device May Customize Therapy, Enable Some to Avoid More Lengthy Treatment
September 23, 2008
SAN DIEGO - Researchers at the University of California, San Diego co-authored a study evaluating the effects of the SAVI® applicator on the first 100 patients to receive treatment with the device. The study concluded that SAVI is effective at sparing nearby healthy tissue from the effects of radiation.
full story [PDF - 174Kb]
Cianna Medical Introduces New SAVI 'Mini' Model at ASTRO
September 22, 2008
ALISO VIEJO, Calif. - Cianna Medical introduced its new 6-1Mini® version of the SAVI applicator at the 50th annual ASTRO meeting in September. The 6-1Mini is the smallest SAVI device in both length and width, and can be used to deliver radiation to the smallest lumpectomy cavities.
full story
"Outstanding" Early Experience with SAVI, Study Reports
September 22, 2008
PHOENIX - A study co-authored by Arizona Oncology Services reports "outstanding" early experience with the SAVI® applicator - particularly for minimal side effects and the device's potential to increase the number of women eligible for breast brachytherapy.
full story [PDF - 174Kb]
SAVI Device for Treatment of Breast Cancer Shows Excellent Cosmetic Results, Few Side Effects
September 22, 2008
FORT MYERS, Fla. - A new study performed at 21st Century Oncology has found that the SAVI® applicator delivered excellent cosmetic results with minimal side effects, particularly for women who had not qualified for breast conservation therapy using a previously available balloon device.
full story [PDF - 174Kb]
Radiation Medical Group is First in Nation to Offer New Breast Cancer Treatment Option
September 18, 2008
SAN DIEGO - Radiation Medical Group, Inc. is the first in the nation to use a new version of the SAVI applicator. The 6-1Mini® applicator is designed for delivering radiation to small or hard-to-reach lumpectomy cavities.
full story [PDF - 174Kb]
SAVI Applicator Outperforms Competing Devices, Study Concludes
May 20, 2008
PHOENIX - A study conducted at Arizona Oncology Services (AOS) found important advantages for the SAVI® applicator over other radiation devices used for accelerated partial breast irradiation (APBI). The study and one other also conducted at AOS were presented as posters at the 2008 World Congress of Brachytherapy.
full story [PDF - 24Kb]
Study Says New Radiation Therapy Technology for Breast Cancer Helps Protect Tissue, Adds Options for Patients
May 13, 2008
SAN DIEGO - New research conducted at Moores Cancer Center at University of California, San Diego shows the SAVI® applicator may provide better protection of healthy tissue than other partial breast irradiation methods. The researchers presented the results of the study at the 2008 World Congress of Brachytherapy.
full story
SAVI Breast Brachytherapy Provides Better Dose Control, Study Finds
March 3, 2008
FORT MYERS, Fla. - Research conducted by 21st Century Oncology shows the SAVI applicator's superior dose control results in a low rate of toxicities, especially skin reactions. The study was presented at the 25th Annual Miami Breast Cancer Conference and was named one of the top three abstracts at the conference.
full story [PDF - 45Kb]
Cianna Medical Completes Funding Round for SAVI Technology
February 26, 2008
ALISO VIEJO, Calif. - Cianna Medical has completed an initial Series A funding round totaling $9 million. The funding will support the further commercialization of the company's proprietary SAVI technology for breast brachytherapy.
full story
Jill Anderson Named President and CEO of Cianna Medical
February 19, 2008
ALISO VIEJO, Calif. - Cianna Medical announced Jill Anderson has been named president and CEO. She has also been named to the company's Board of Directors.
full story
New Research at UCSD Shows SAVI Breast Brachytherapy Has Multiple Benefits
December 5, 2007
SAN DIEGO - Research performed by the Rebecca and John Moores UCSD Cancer Center that was presented at RSNA 2007 shows the SAVI™ applicator provides multiple benefits for patients, breast surgeons and radiation oncologists.
full story
New Technology to Treat Breast Cancer Shows Promise in Early Application
November 19, 2007
SAN DIEGO -UCSD Cancer Center announces that they will present the initial outcomes of their use of the SAVI device at RSNA, 2007. Physicians at UCSD report that the SAVI applicator allows radiation to be delivered with precision to the cancerous site, avoiding healthy tissue, and provides multiple benefits to the patients, breast surgeons, and radiation oncologists.
full story [PDF - 41Kb]
SAVI™ Applicator for Breast Brachytherapy May Optimize Treatment and Spare Healthy Tissue, Study Finds
October 25, 2007
PHOENIX - A study conducted at Arizona Oncology Services found that the new SAVI™ applicator optimizes the distribution of the radiation dose to the targeted area while reducing radiation exposure to nearby, healthy body structures like the skin surface or chest wall. The results of the study were released in a poster presentation at the 2007 annual meeting of the American Society for Therapeutic Radiation and Oncology.
full story [PDF - 30Kb]
SAVI™ Breast Brachytherapy Reaches 100-Patient Milestone
October 22, 2007
ALISO VIEJO, Calif. - Cianna Medical announced that 100 patients have been treated with the SAVI™ applicator-a significant milestone for the company and for the breast brachytherapy field.
full story
SAVI™ Produces Promising Results, Doctors Report at ASCO Meeting
October 9, 2007
ALISO VIEJO, Calif. - The SAVI™ applicator used in breast brachytherapy produced promising results in an early clinical trial with patients, according to a study presented at the American Society of Clinical Oncology's 2007 breast cancer symposium.
full story
Cianna Medical Will Continue Innovation in SAVI Breast Brachytherapy Begun by BioLucent
September 20, 2007
ALISO VIEJO, Calif. - Cianna Medical has been created as a new company to focus exclusively on the SAVI™ applicator, its innovative breast brachytherapy technology. The creation of Cianna Medical comes with the completion of Hologic, Inc.'s acquisition of BioLucent and its MammoPad® breast cushion business.
full story
BioLucent Creates New Company, Cianna Medical, to Continue Innovation in SAVI Breast Brachytherapy
June 21, 2007
ALISO VIEJO, Calif.-Cianna Medical will be the new name for the company that will manufacture and market the SAVI™ applicator, the recently introduced breast brachytherapy device. Cianna will be created as a spin-off from BioLucent, Inc. following the acquisition of BioLucent's MammoPad® business by Hologic, Inc.
full story
Hologic to Acquire BioLucent, Inc.
June 21, 2007
BEDFORD, MA - Hologic, Inc. (NASDAQ: HOLX), a leading provider of diagnostic imaging and state-of-the-art digital imaging systems directed towards women's health, announced it has entered into a definitive agreement to acquire BioLucent, Inc. and it's MammoPad® breast cushion business. Concurrently with the closing of the transaction, BioLucent will spin-off its brachytherapy business into a newly created company, which will remain an independent company.
full story [PDF - 22Kb]
UCSD's Moores Cancer Center First in California to Offer Advanced Breast Cancer Treatment
May 21, 2007
SAN DIEGO - The Rebecca and John Moores UCSD Cancer Center is the first facility in California - and the second in the nation - to offer the SAVI™ applicator as part of breast conservation therapy.
full story [PDF - 41Kb]
New Breast Cancer Treatment May Reduce Radiation to Healthy Tissue, Study Shows
May 2, 2007
PHOENIX - A study conducted by Arizona Oncology Services (AOS) shows that the SAVI™ applicator may reduce the amount of radiation delivered to healthy skin during breast cancer treatment. The results were released in a poster presentation at the 2007 American Brachytherapy Society annual meeting in Chicago.
full story [PDF - 29Kb]
Experts Discuss Benefits of New SAVI Breast Cancer Treatment
April 18, 2007
SAN FRANCISCO - Leading experts on breast cancer treatment discussed the use and benefits of the new SAVI™ applicator during a panel discussion held April 12 in San Francisco. The panel took place in conjunction with the 2007 American Society of Breast Disease Annual Symposium.
full story
Arizona Oncology Services Is First to Offer Advanced Breast Cancer Treatment
November 6, 2006
PHOENIX - Arizona Oncology Services announced it is the first medical facility in the nation to treat a patient using the SAVI™ applicator. Robert Kuske, M.D., a leading radiation oncologist, performed the first two cases using the new applicator.
full story [PDF - 21Kb]
BioLucent Introduces New SAVI Breast Brachytherapy Device at ASTRO
October 26, 2006
ALISO VIEJO, Calif. - BioLucent announced the launch of the SAVI™ applicator. The company will introduce the product at the annual meeting of the American Society for Therapeutic Radiation and Oncology (ASTRO), November 5-9, in Philadelphia. The SAVI device offers a multi-catheter, single-entry approach to breast brachytherapy as part of breast-conserving cancer treatment.
full story
BioLucent Receives FDA Clearance for SAVI, a New Breast Brachytherapy Device
October 24, 2006
ALISO VIEJO, Calif. - BioLucent, Inc. announced that it has received 510(k) clearance from the U. S. Food and Drug Administration for the SAVI™ applicator, a multi-catheter device that provides single-entry breast brachytherapy. SAVI is for use in accelerated partial breast irradiation (APBI) and is designed to provide physicists and radiation oncologists with more treatment planning flexibility.
full story